Patent details

Basic Information

Publication number:

EP2598129

PCT Application Number:

PCT/EP/2011/060939

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117389973

PCT Publication Number:

WO/2012/001065

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF ALPHA-ADRENERGIC RECEPTOR AGONIST FOR PREVENTING OR TREATING SKIN TUMOR

French Title of Invention:

UTILISATION D'UN AGONIST ALPHA-ADRENERGIQUE RECEPTEUR POUR LA PRÉVENTION OU LE TRAITEMENT DE TUMEUR DE LA PEAU

German Title of Invention:

VERWENDUNG EINE ALPHA-ADRENERGE REZEPTOR AGONIST ZUR PRÄVENTION ODER BEHANDLUNG VON HAUTTUMOR

SPC Number:

Dates

Filing date:

29/06/2011

Grant date:

11/05/2016

EP Publication Date:

11/05/2016

PCT Publication Date:

05/01/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/06/2013

EP B1 Publication Date:

11/05/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/06/2016

Expiration date:

29/06/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/06/2011

 

 

Name:

Galderma Research & Development

Address:

2400 Route des Colles Les Templiers, 06410 Biot, France (FR)

Inventor

1

Name:

BOUVIER Guy

Address:

France (FR)

2

Name:

LEONI Matthew James

Address:

United States (US)

3

Name:

GRAEBER Michael

Address:

United States (US)

Priority

Priority Number:

344333 P

Priority Date:

30/06/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/137;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages